Wilbanks Smith & Thomas Asset Management LLC Chroma Dex Corp. Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 08, 2019	SELL	$2.8 - $4.22 $56,000 - $84,400	-20,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.5 - $4.91 $70,000 - $98,200	20,000 New	20,000 $86,000

Others Institutions Holding CDXC

# of Institutions

129

Shares Held

21.9M

Call Options Held

203K

Put Options Held

23.9K

Vanguard Group Inc Valley Forge, PA

3.39M
Shares

$19.7 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.12M
Shares

$18.1 Million
0.0% of portfolio
Tieton Capital Management, LLC Yakima, WA

2.59M
Shares

$15.1 Million
5.52% of portfolio
Iconiq Capital, LLC San Francisco, CA

1.3M
Shares

$7.54 Million
0.14% of portfolio
Geode Capital Management, LLC Boston, MA

1.15M
Shares

$6.72 Million
0.0% of portfolio

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $398M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account